MARKET

RMD

RMD

Resmed
NYSE

Real-time Quotes | Nasdaq Last Sale

286.18
-4.24
-1.46%
Closed 19:48 09/16 EDT
OPEN
289.26
PREV CLOSE
290.42
HIGH
289.26
LOW
282.52
VOLUME
621.21K
TURNOVER
--
52 WEEK HIGH
301.34
52 WEEK LOW
165.72
MARKET CAP
41.69B
P/E (TTM)
88.38
1D
5D
1M
3M
1Y
5Y
Insider Sell: ResMed
MT Newswires · 18h ago
4 Soaring Medical Device Stocks to Buy Now
StockNews.com · 2d ago
Insider Sell: Resmed
MT Newswires · 3d ago
Resmed Inc (RMD) CFO Brett Sandercock Sold $1.5 million of Shares
GuruFocus News · 3d ago
Oppenheimer Adjusts ResMed PT to $312 From $300, Maintains Outperform Rating
MT Newswires · 09/09 13:45
ResMed (RMD)-Backed Landmark ALASKA Study Favors PAP Therapy
A late-breaking abstract from ResMed (RMD) supported landmark ALASKA study reported that treatment with PAP therapy improves the likelihood of longevity in sleep apnea patients
Zacks · 09/09 13:41
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8)
Benzinga · 09/09 12:17
Philips is a buy after recent weakness; Siemens Healthineers a long-term hold - Jefferies
Jefferies has initiated the coverage of Koninklijke Philips (NYSE:PHG) and Siemens Healthineers (NYSE:SHG) with buy and hold ratings, respectively. Philips is poised to generate strong annual revenue growth given solid
Seekingalpha · 09/08 13:43
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of RMD. Analyze the recent business situations of Resmed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average RMD stock price target is 261.67 with a high estimate of 312.00 and a low estimate of 230.00.
EPS
Institutional Holdings
Institutions: 835
Institutional Holdings: 103.92M
% Owned: 71.33%
Shares Outstanding: 145.68M
TypeInstitutionsShares
Increased
197
2.74M
New
71
1.25M
Decreased
247
4.79M
Sold Out
65
806.31K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.49%
Healthcare Equipment & Supplies
-0.15%
Key Executives
Non-Executive Chairman
Peter Farrell
President/Chief Operating Officer
Robert Douglas
Chief Executive Officer/Director
Michael Farrell
Chief Financial Officer
Brett Sandercock
Corporate Executive
Bobby Ghoshal
Corporate Executive
Jim Hollingshead
Corporate Executive
Justin Leong
Chief Administrative Officer/General Counsel/Secretary
David Pendarvis
Lead Director/Independent Director
Ronald Taylor
Independent Director
Carol Burt
Independent Director
Jan De Witte
Independent Director
Karen Drexler
Independent Director
Harjit Gill
Independent Director
Richard Sulpizio
Declaration Date
Dividend Per Share
Ex-Div Date
08/05/2021
Dividend USD 0.42
08/18/2021
04/29/2021
Dividend USD 0.39
05/12/2021
01/28/2021
Dividend USD 0.39
02/10/2021
10/29/2020
Dividend USD 0.39
11/10/2020
08/05/2020
Dividend USD 0.39
08/19/2020
04/30/2020
Dividend USD 0.39
05/13/2020
01/30/2020
Dividend USD 0.39
02/12/2020
10/24/2019
Dividend USD 0.39
11/06/2019
07/25/2019
Dividend USD 0.39
08/14/2019
05/02/2019
Dividend USD 0.37
05/08/2019
01/24/2019
Dividend USD 0.37
02/06/2019
10/25/2018
Dividend USD 0.37
11/07/2018
08/02/2018
Dividend USD 0.37
08/15/2018
04/26/2018
Dividend USD 0.35
05/09/2018
01/22/2018
Dividend USD 0.35
02/07/2018
10/25/2017
Dividend USD 0.35
11/08/2017
08/02/2017
Dividend USD 0.35
08/15/2017
04/28/2017
Dividend USD 0.33
05/09/2017
01/24/2017
Dividend USD 0.33
02/07/2017
10/26/2016
Dividend USD 0.33
11/08/2016
About RMD
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.

Webull offers kinds of ResMed Inc. stock information, including NYSE:RMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RMD stock methods without spending real money on the virtual paper trading platform.